Research involving cancer-targeting silica particles, known as Cornell dots, has shown that the particles can neutralize nutrient-deprived cancer cells by a cell-death process called ferroptosis.
An innovative method that uses human embryonic stem cells to model type 2 diabetes caused by genetic mutations may enable researchers to identify drugs that could treat the disease.
New research by Weill Cornell Medicine investigators could offer researchers a new scientific avenue to pursue treatments for X-linked chromosomal diseases in females such as Rett syndrome.
Weill Cornell Medicine and Cornell's Samuel Curtis Johnson Graduate School of Management today announced a new dual MBA/M.S. degree program for health care leaders.
MRI-guided ultrasound ablation, a new noninvasive treatment for tremors being offered at Weill Cornell Medicine, is helping people with essential tremors.
Researchers from the College of Engineering and Weill Cornell Medicine will fight the spread of breast cancer and other cancers with a $9.3M, five-year grant from the National Cancer Institute.
Why do some teams become derailed by conflict, while others manage to work through conflicts to deliver great performance? A 2008 landmark study co-authored by Johnson's Beta Mannix explains why.
After a successful 10-year capital campaign, Cornell in fiscal year 2016 gathered strong philanthropic support and setting a new record of $601.8 million in cash gifts to the university.
